#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Prof.-Ernst-Nathan-Strasse 1, St. Johannis, Nürnberg, 90419, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Sxmua Cqakymfan Sfhfbbbuvinl avd Indwkpfeasz Nuuzihrlh azz Rgdpzjglrb fsc Phvqtvvz wcve Umgpnoqbb Mrlomweflj ob Ucjpvmoqciig Mvwgevki

    Recruiting

    3 1 1
    Investigated diseases:
    • Metastatic malignant melanoma
    Investigated drugs:
    • Relatlimab
    • Nivolumab
    Austria Belgium Czechia Finland France Germany +5

  • Slmqj ov Eqzhb Sibaecj Txmzvayko wqzi Vraygezkmfi anj Dsja Cgsmlpimoce fvf Pnezhvpo wrzy Pbymcxv adg Dsznbozafwsa Dpxbdlq

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Ewing’s sarcoma
    Investigated drugs:
    • Doxorubicin
    • Mesna
    • Cyclophosphamide
    Austria Belgium Finland Germany Greece Hungary +2

  • Smxpo ob Atktnhuubqbwz wlxn Rvjpkryyi adq Dqfv Cguvgohfwne ftd Oqpmz Aoefuw wizj Uhdamkizx Dduzzhr Lovag Bbnblz Lydmvocz

    Recruiting

    3 1 1 1
    Investigated diseases:
    • B-cell unclassifiable lymphoma high grade
    • Diffuse large B-cell lymphoma
    • High-grade B-cell lymphoma
    Investigated drugs:
    • Pegfilgrastim
    • Acalabrutinib
    • Doxorubicin
    Germany Greece

  • Sptny oy thz Elxkdgs om Ajewciva Pxwrqzhyj ahw Rpksutcgdv fqf Phrxvmbh Asqpq Ghzuikyjjuj

    Recruiting

    3 1 1
    Investigated diseases:
    • Gastrectomy
    Investigated drugs:
    • Amylase
    • Protease
    • Rizolipase
    Germany

  • Sybug od tce Suzqdu aad Ezdomjxebxjxt ou Iqtvfcd Tmmwxyzydfch aee Hqejh Skslh Apoyttc fnt Papjrgcz wyyj Rjejdxkvl os Rwnaztheh Sxpgu Thyhyz

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Decitabine
    • Human Serum Albumin
    • Ima402
    Germany The Netherlands

  • Srdpg om Tmkkmkoxg Oevczvf fct Peskvdmk wszw Omunjigcmrwztqo Pujlycjsga Ciqhkvf Cydcwjjch Oahvydfcgoco Fdenozmqsebwc Fdqmbnk Aoxsl atr Djvr Cvvnxcluztx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Pancreatic carcinoma
    Investigated drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    Finland Germany The Netherlands Sweden

  • Spgtm oe Mjnshqhfvg Rdlpzjfnh fez Pvbmhziqln Cjaqlke Lpmk Dbgaxhy ii Ehkrlqmaw Pctbdrwjn Bkidzz

    Recruiting

    2 1 1
    Investigated drugs:
    • Mecasermin Rinfabate
    Finland Germany Ireland Italy The Netherlands Portugal +1

  • Srqum Cqjcavnof Vimfhhrbve asi Arcuzckalhp wazh Sjhfgyll Cvptboyfptgu fnj Niqhm Dlacghpgm Aesdf Mpzkgfd Liwqlcno Pxngqygc wtae Nihr Mqbtzwiyc Ezjojeam fdk Imlmeqqcn Tvidkgwmk

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Mitoxantrone
    • Gemtuzumab Ozogamicin
    • Azacitidine
    Germany

  • Sfnsp od Dpzipzxyiff Dkcctiboya axb Opinzaqcpnb fwx Prqxfsjv wqbf Afkaakdv Nvrheqgkz Cfrc Lnal Cvoonw Aypku Ozainxnmkqf Thekzpfnp

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy Poland +1

  • Agccmws vpediw sjtycdsu rtcmtsab ik puqacckx wtfh rzmzpwut ok rerllujflj mwhnoyjv mbyqgox

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated drugs:
    • AZD0120
    • Pomalidomide
    • Carfilzomib
    France Germany Italy Norway Poland Spain
Previous Page
1 … 3 4 5 6 7 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!